FBI Probes Jim Irsay Death Over Prescription Drugs, Ketamine Use and Doctor Relationship: Report

FBI Investigation into Jim Irsay’s Death and Prescription Drug Use

Federal authorities have initiated a comprehensive investigation into the death of Jim Irsay, the longtime owner of the Indianapolis Colts, with a particular focus on his use of prescription medications and ketamine treatments. The inquiry also scrutinizes Irsay’s relationship with Dr. Harry Haroutunian, a California-based addiction specialist who treated him in the months preceding his death. According to reports from The Washington Post, the FBI issued a federal grand jury subpoena earlier this month, demanding records related to Irsay’s death, his alleged consumption of both legal and illegal drugs, and his interactions with Dr. Haroutunian.

The investigation has included several days of activity in Indianapolis, where federal agents gathered information as part of the ongoing probe. While the FBI has declined to comment publicly on the matter, the Colts organization has acknowledged awareness of the investigation but stated they have not been contacted or served with subpoenas. Dan Emerson, the Colts’ Chief Legal Officer, confirmed that no subpoenas have been issued to the team or its current employees.

Background on Jim Irsay’s Health and Addiction Issues

Jim Irsay, who took ownership of the Colts in 1997, passed away in May 2024 at the age of 65. Throughout his life, Irsay faced numerous health challenges, including battles with drug and alcohol addiction. He openly admitted to having entered rehabilitation facilities at least 15 times. In January 2024, the Colts announced that Irsay was undergoing treatment for a severe respiratory illness, and by February, he shared on social media that he was “on the mend.”

Despite these health struggles, Irsay remained a prominent figure in the NFL, known for his leadership and dedication to the Colts franchise. However, his history of substance abuse and health complications has come under renewed scrutiny following his death.

Details Surrounding Prescription Drug and Ketamine Use

One of the critical aspects of the FBI’s investigation involves Irsay’s use of prescription opioids and ketamine, which were reportedly prescribed by Dr. Haroutunian. In December 2023, police responded to a call at Irsay’s Indianapolis residence, where he was found unresponsive in bed during what was described as a “suspected overdose.” Irsay later disputed the overdose claim, emphasizing that the media had jumped to conclusions based on his past.

According to The Washington Post, Dr. Haroutunian prescribed Irsay over 200 opioid pills prior to the December incident. The investigation also revealed that Irsay received ketamine treatments during a period of relapse, with at least two overdose incidents occurring—one at his Indianapolis home and another at a rental property in Miami. These revelations have raised questions about the appropriateness of the medical care Irsay received and the potential role of his doctor in his declining health.

The Role of Dr. Harry Haroutunian in Jim Irsay’s Final Months

Dr. Harry Haroutunian, an addiction specialist based in California, played a significant role in Jim Irsay’s treatment during the final months of his life. Haroutunian signed Irsay’s death certificate, citing cardiac arrest caused by acute pneumonia as the primary cause of death, with two heart conditions listed as contributing factors. Notably, no official autopsy was conducted, which has added complexity to the investigation.

The FBI’s grand jury subpoena seeks to obtain detailed records of Irsay’s treatment under Haroutunian’s care, including prescriptions and medical notes. The focus on the doctor-patient relationship aims to determine whether there was any misconduct or negligence in managing Irsay’s health and substance use.

Legal and Professional Repercussions

The ongoing investigation has prompted responses from both the Colts organization and legal representatives. While the Colts have expressed cooperation with authorities, they maintain that no subpoenas have been served to the team or its employees. The situation remains fluid as federal agents continue to gather evidence.

Jim Irsay’s history includes a 2014 arrest for operating while intoxicated (OWI), which resulted in a six-game suspension and a $500,000 fine imposed by the NFL. Irsay publicly reflected on the incident, suggesting that his status as a White billionaire influenced the severity of the consequences. His family’s legacy with the Colts dates back to 1972 when his father purchased the team and later relocated it to Indianapolis in 1984. Irsay himself served as the team’s general manager before becoming the youngest NFL owner at age 37.

Conclusion

The FBI’s probe into Jim Irsay’s death highlights the complex interplay between prescription drug use, addiction treatment, and medical oversight. As investigators delve deeper into the circumstances surrounding his passing, questions about the role of ketamine treatments and the involvement of Dr. Harry Haroutunian remain central to the inquiry. For fans and followers of the Indianapolis Colts, this investigation sheds light on the challenges faced by a prominent sports figure battling health and addiction issues.

Stay informed on this developing story and other sports news by subscribing to our newsletter and following our updates. Don’t miss out on the latest insights and comprehensive coverage—sign up today!